NEW YORK, Jan. 10, 2022 (GLOBE NEWSWIRE) -- Scopus BioPharma Inc. (Nasdaq: SCPS) (“Scopus” or the “Company”) today announced that it has filed an amendment to the Current Report on Form 8 ...

NEW YORK, Oct. 18, 2022 (GLOBE NEWSWIRE) -- Scopus BioPharma Inc. (Nasdaq: “SCPS”), a biopharmaceutical company developing transformational therapeutics for serious diseases with significant ...

NEW YORK, April 26, 2021 /PRNewswire/ — Scopus BioPharma Inc. (Nasdaq: “SCPS”) today announced the submission of an investigational new drug application (“IND”) to the United States Food ...

NEW YORK, Sept. 02, 2021 (GLOBE NEWSWIRE) -- Scopus BioPharma Inc. (Nasdaq: “SCPS”), a clinical-stage biopharmaceutical company developing transformational therapeutics for ...

Scopus BioPharma has filed to raise $6 million in an IPO. The firm is advancing treatment candidates for lymphoma and systemic sclerosis. SCPS is thinly capitalized and is still at pre-Phase 1 ...

Explore Scopus BioPharma stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for SCPS. Why AMC Entertainment Shares Are Trading Lower By Around 13%? Here Are 59 ...

NEW YORK, Sept. 23, 2021 (GLOBE NEWSWIRE) -- Scopus BioPharma Inc. (Nasdaq: “SCPS”), a clinical-stage biopharmaceutical company developing transformational therapeutics for serious diseases ...

(RTTNews) - Shares of Scopus BioPharma Inc. (SCPS) are surging over 70% on Wednesday morning after despite no stock-related new release from the company. SCPS is currently trading at $22.28 ...

Scopus BioPharma (SCPS) - Shares of the company gained over 10% in after-hours trading on Wednesday after finishing 7% higher in its debut as a public company. The drugmaker earlier priced its $2. ...

Short interest in Scopus BioPharma Inc (OTC:SCPS) decreased during the last reporting period, falling from 10.51K to 10.51K. This put 0.03% of the company's publicly available shares short.